美国胸科学会研究声明:间质性肺疾病研究中种族、民族、性别与社会性别的包容性公平
该美国胸科学会声明通过多学科委员会文献综述,强调间质性肺疾病(ILD)研究中种族、民族、性别与社会性别因素的重要性,总结照护差异与不平等证据,并提出促进临床研究公平纳入的共识建议。综述发现少数群体在ILD研究中尤其治疗临床试验中代表性不足,需改变亚组数据的收集、分析与报告方式。
要点
- ILD研究需重视种族、民族、性别与社会性别因素对公平照护的影响。
- 少数群体在ILD临床研究尤其治疗试验中代表性不足。
- 建议改变亚组数据收集分析报告方式以促进公平纳入。
核心结论
- 改善ILD研究公平性对提升研究结果对全球ILD人群的普适性与适用性至关重要。
- 实现该目标需研究者、机构、资助方与患者社区等所有利益相关方协调行动。
研究设计与样本
- 美国胸科学会声明由ILD、健康公平、性别/社会性别及种族/民族公平多学科专家委员会制定。
- 委员会对ILD差异相关文献进行综合综述,识别按种族、民族、性别与社会性别划分的临床试验参与和结局研究。
- 通过迭代讨论与全体成员共识形成公平纳入研究的建议。
主要发现
- 综述识别出ILD在流行病学、诊断、管理、治疗可及性与临床结局等领域存在显著差异。
- 少数群体在ILD研究中代表性不足,尤其在ILD治疗临床试验中。
关键数值与推荐
- ILD研究与实践须基于包容性做法。
- 应改变ILD临床试验中亚组数据的收集、分析与报告方式,并在研究各层面更关注少数群体纳入。
临床怎么用
- 在ILD临床研究中采用包容性实践,关注少数群体纳入。
- 调整亚组数据的收集、分析与报告方式以支持公平性评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Rationale: Equitable care for all individuals living with interstitial lung disease (ILD) must be rooted in rigorous, high-quality research that is globally representative and inclusive. Objectives: The objectives of this American Thoracic Society Statement are to emphasize the importance of racial, ethnic, sex, and gender considerations in ILD research; summarize existing evidence on differences and disparities in ILD care; and suggest practical recommendations to promote equitable inclusion in clinical research. Methods: A multidisciplinary committee of experts in ILD, health equity, sex/gender, and race/ethnicity equity conducted a comprehensive review of the literature related to disparities in ILD. The group identified relevant studies pertaining to clinical trial participation and outcomes by race, ethnicity, sex, and gender. Consensus-based recommendations for equitable inclusion in research were developed through iterative discussion and agreement by all members. Main Results: The review identified significant disparities across ILD domains, including epidemiology, diagnosis, management, treatment access, and clinical outcomes. Minority populations remain underrepresented in ILD research, especially in clinical trials of ILD treatment. Research efforts and programs in ILD must be based on inclusive practices. This can be accomplished by changing how subgroup data are collected, analyzed, and reported in ILD clinical trials, with greater attention to the inclusion of minority populations, at all levels of research. Conclusions: Improving equity in ILD research is paramount to enhancing the generalizability and applicability of findings to the global ILD population. This goal will require coordinated action by all stakeholders, including researchers, institutions, funding agencies, and patient communities.
引用
- Assayag D, Adegunsoye A, Khor YH, et al. Racial, Ethnic, Sex, and Gender Equity for Inclusive Interstitial Lung Disease Research: An Official American Thoracic Society Research Statement. Am J Respir Crit Care Med. 2025. PMID: 41324350. doi:10.1164/rccm.202509-2336ST
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。